Health and Ethics Policies of the AMA House of Delegates. czerwiec 2008. [dostęp 2015-05-10]. [zarchiwizowane z tego adresu]. Cytat: H-30.997 Dual Disease Classification of Alcoholism: The AMA reaffirms its policy endorsing the dual classification of alcoholism under both the psychiatric and medical sections of the International Classification of Diseases. (Res. 22, I-79; Reaffirmed: CLRPD Rep. B, I-89; Reaffirmed: CLRPD Rep. B, I-90; Reaffirmed by CSA Rep. 14, A-97; Reaffirmed: CSAPH Rep. 3, A-07)
Romeo J., Wärnberg J., Nova E., Díaz L.E., Gómez-Martinez S. i inni. Moderate alcohol consumption and the immune system: a review. „The British Journal of Nutrition”. 98 Suppl 1, s. S111-5, październik 2007. DOI: 10.1017/S0007114507838049. PMID: 17922947.
Agarwal-Kozlowski K., Agarwal D.P. [Genetic predisposition for alcoholism]. „Therapeutische Umschau”. 57 (4), s. 179–84, kwiecień 2000. DOI: 10.1024/0040-5930.57.4.179. PMID: 10804873.
Higgins-Biddle J.C., Babor T.F. A review of the Alcohol Use Disorders Identification Test (AUDIT), AUDIT-C, and USAUDIT for screening in the United States: Past issues and future directions. „The American Journal of Drug and Alcohol Abuse”. 44 (6), s. 578–586, 2018. DOI: 10.1080/00952990.2018.1456545. PMID: 29723083. PMCID: PMC6217805.
Morgan-Lopez A.A., Fals-Stewart W. Analytic complexities associated with group therapy in substance abuse treatment research: problems, recommendations, and future directions. „Experimental and Clinical Psychopharmacology”. 14 (2), s. 265–273, maj 2006. DOI: 10.1037/1064-1297.14.2.265. PMID: 16756430. PMCID: PMC4631029.
Tusa A.L., Burgholzer J.A. Came to believe: spirituality as a mechanism of change in alcoholics anonymous: a review of the literature from 1992 to 2012. „Journal of Addictions Nursing”. 24 (4), s. 237–246, 2013. DOI: 10.1097/jan.0000000000000003. PMID: 24335771.
((GBD 2013 Mortality Causes of Death Collaborators)). Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. „Lancet”. 385 (9963), s. 117–171, styczeń 2015. DOI: 10.1016/S0140-6736(14)61682-2. PMID: 25530442. PMCID: PMC4340604.
OlivierO.AmeisenOlivierO., Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician, „Alcohol and Alcoholism”, 40 (2), 2004, s. 147–150, DOI: 10.1093/alcalc/agh130.
L.L.LeggioL.L., J.C.J.C.GarbuttJ.C.J.C., G.G.AddoloratoG.G., Effectiveness and safety of baclofen in the treatment of alcohol dependent patients, „CNS & Neurological Disorders Drug Targets”, 9 (1), 2010, s. 33–44, DOI: 10.2174/187152710790966614, PMID: 20201813.
JiaJ.LiuJiaJ., Lu-NingL.N.WangLu-NingL.N., Baclofen for alcohol withdrawal, „The Cochrane Database of Systematic Reviews”, 8, 2017, CD008502, DOI: 10.1002/14651858.CD008502.pub5, PMID: 28822350.
Teri S.T.S.KrebsTeri S.T.S., Pål-ØrjanP.Ø.JohansenPål-ØrjanP.Ø., Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials, „Journal of Psychopharmacology”, 26 (7), 2012, s. 994–1002, DOI: 10.1177/0269881112439253.
Romeo J., Wärnberg J., Nova E., Díaz L.E., Gómez-Martinez S. i inni. Moderate alcohol consumption and the immune system: a review. „The British Journal of Nutrition”. 98 Suppl 1, s. S111-5, październik 2007. DOI: 10.1017/S0007114507838049. PMID: 17922947.
Moonat S., Pandey S.C. Stress, epigenetics, and alcoholism. „Alcohol Research”. 34 (4), s. 495–505, 2012. PMID: 23584115. PMCID: PMC3860391.
Agarwal-Kozlowski K., Agarwal D.P. [Genetic predisposition for alcoholism]. „Therapeutische Umschau”. 57 (4), s. 179–84, kwiecień 2000. DOI: 10.1024/0040-5930.57.4.179. PMID: 10804873.
Mersy D.J. Recognition of alcohol and substance abuse. „American Family Physician”. 67 (7), s. 1529–1532, April 2003. PMID: 12722853.
Higgins-Biddle J.C., Babor T.F. A review of the Alcohol Use Disorders Identification Test (AUDIT), AUDIT-C, and USAUDIT for screening in the United States: Past issues and future directions. „The American Journal of Drug and Alcohol Abuse”. 44 (6), s. 578–586, 2018. DOI: 10.1080/00952990.2018.1456545. PMID: 29723083. PMCID: PMC6217805.
Blondell R.D. Ambulatory detoxification of patients with alcohol dependence. „American Family Physician”. 71 (3), s. 495–502, luty 2005. PMID: 15712624.
Testino G., Leone S., Borro P. Treatment of alcohol dependence: recent progress and reduction of consumption. „Minerva Medica”. 105 (6), s. 447–66, grudzień 2014. PMID: 25392958.
Morgan-Lopez A.A., Fals-Stewart W. Analytic complexities associated with group therapy in substance abuse treatment research: problems, recommendations, and future directions. „Experimental and Clinical Psychopharmacology”. 14 (2), s. 265–273, maj 2006. DOI: 10.1037/1064-1297.14.2.265. PMID: 16756430. PMCID: PMC4631029.
Tusa A.L., Burgholzer J.A. Came to believe: spirituality as a mechanism of change in alcoholics anonymous: a review of the literature from 1992 to 2012. „Journal of Addictions Nursing”. 24 (4), s. 237–246, 2013. DOI: 10.1097/jan.0000000000000003. PMID: 24335771.
((GBD 2013 Mortality Causes of Death Collaborators)). Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. „Lancet”. 385 (9963), s. 117–171, styczeń 2015. DOI: 10.1016/S0140-6736(14)61682-2. PMID: 25530442. PMCID: PMC4340604.
Barbara J.B.J.MasonBarbara J.B.J., Charles J.Ch.J.HeyserCharles J.Ch.J., Acamprosate: A prototypic neuromodulator in the treatment of alcohol dependence, „CNS & neurological disorders drug targets”, 9 (1), 2010, s. 23–32, ISSN1871-5273, PMID: 20201812, PMCID: PMC2853976 [dostęp 2017-08-04].
L.L.LeggioL.L., J.C.J.C.GarbuttJ.C.J.C., G.G.AddoloratoG.G., Effectiveness and safety of baclofen in the treatment of alcohol dependent patients, „CNS & Neurological Disorders Drug Targets”, 9 (1), 2010, s. 33–44, DOI: 10.2174/187152710790966614, PMID: 20201813.
JiaJ.LiuJiaJ., Lu-NingL.N.WangLu-NingL.N., Baclofen for alcohol withdrawal, „The Cochrane Database of Systematic Reviews”, 8, 2017, CD008502, DOI: 10.1002/14651858.CD008502.pub5, PMID: 28822350.
Health and Ethics Policies of the AMA House of Delegates. czerwiec 2008. [dostęp 2015-05-10]. [zarchiwizowane z tego adresu]. Cytat: H-30.997 Dual Disease Classification of Alcoholism: The AMA reaffirms its policy endorsing the dual classification of alcoholism under both the psychiatric and medical sections of the International Classification of Diseases. (Res. 22, I-79; Reaffirmed: CLRPD Rep. B, I-89; Reaffirmed: CLRPD Rep. B, I-90; Reaffirmed by CSA Rep. 14, A-97; Reaffirmed: CSAPH Rep. 3, A-07)
World Health Organization: Alcohol. styczeń 2015. [dostęp 2015-05-10]. [zarchiwizowane z tego adresu].
Bohdan TadeuszB.T.WoronowiczBohdan TadeuszB.T., Alkoholizm jest chorobą, wyd. 2, Warszawa: Państwowa Agencja Rozwiązywania Problemów Alkoholowych, 1998, ISBN 83-86103-85-X, OCLC749913950. Brak numerów stron w książce
Barbara J.B.J.MasonBarbara J.B.J., Charles J.Ch.J.HeyserCharles J.Ch.J., Acamprosate: A prototypic neuromodulator in the treatment of alcohol dependence, „CNS & neurological disorders drug targets”, 9 (1), 2010, s. 23–32, ISSN1871-5273, PMID: 20201812, PMCID: PMC2853976 [dostęp 2017-08-04].
